检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]大连医科大学研究生院,辽宁大连116027 [2]沈阳军区总医院神经内科,沈阳110840
出 处:《解放军医药杂志》2016年第3期18-21,共4页Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基 金:辽宁省科技攻关计划(2013225089,2014225008)
摘 要:目的采用大鼠大脑中动脉梗塞(MCAO)模型,探讨依达拉奉治疗急性脑梗死的最佳治疗时间窗。方法将MCAO模型大鼠随机分为A、B、C、D和E组(n=10)。A、B、C、D组分别于造模后0.5 h、1 h、1.5 h、2 h通过尾静脉给予3 mg/kg的依达拉奉,E组于造模后给予等量的生理盐水。于梗死后24 h进行神经功能缺损评分,并测量脑梗死体积。结果 A、B、C组神经功能缺损评分和脑梗死体积均低于E组(P<0.05,P<0.01),其中B组与E组比较差异更显著(P<0.01),B组低于A、C、D组(P<0.05,P<0.01),B组与D组比较差异更显著(P<0.01)。结论对大鼠MCAO模型,依达拉奉具有神经保护作用,且其神经保护作用有治疗时间窗。Objective To investigate the golden hour of Edaravone neuroprotective effect in treatment of rats with acute cerebral infarction using middle cerebral artery occlusion( MCAO) models. Methods A total of 50 MCAO rat models were randomly divided into group A,B,C,D and E( n = 10 in each group). Group A,B,C and D were respectively injected with 3 mg / kg Edaravone via caudal vein infusion at 0. 5 h,1 h,1. 5 h and 2 h after models establishment,while the control group received the same volume of physiological saline after models establishment. The neurologic impairment scores were detected at 24 h after infarct,and the infarct volumes were also measured. Results The values of neurologic impairment scores and infarct volumes in group A,B and C were significantly lower than those in group E respectively( P〈0. 05,P〈0. 01),and the differences between group B and E were more significant( P〈0. 01),and the values in group B were lower than those in group A,C and D respectively( P〈0. 05,P〈0. 01),and the differences between group B and D were more significant( P〈0. 01). Conclusion Edaravone has neuroprotective effect in MCAO rats,and the effect has the golden hour.
关 键 词:大鼠 Sprague-Dawley 梗死 大脑中动脉 依达拉奉 神经保护药 治疗时间窗
分 类 号:R743.33[医药卫生—神经病学与精神病学] R-332[医药卫生—临床医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117